植入式心脏转复除颤器导线故障的长期预后。
Long-term Outcome of Implantable Cardioverter/Defibrillator Lead Failure.
机构信息
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
出版信息
JAMA Intern Med. 2020 Feb 1;180(2):322-324. doi: 10.1001/jamainternmed.2019.4717.
Abstract
This study compares outcomes of a recalled implantable cardioverter/defibrillator lead with a control lead in individuals in Iceland.
摘要
本研究比较了冰岛个体中召回的植入式心脏转复除颤器导线与对照导线的结果。
相似文献
1
Long-term Outcome of Implantable Cardioverter/Defibrillator Lead Failure.
JAMA Intern Med. 2020 Feb 1;180(2):322-324. doi: 10.1001/jamainternmed.2019.4717.
2
Implantable cardioverter defibrillators in pediatric patients: off-label devices for orphan diseases.
J Cardiovasc Electrophysiol. 2005 Jan;16(1):74-5. doi: 10.1046/j.1540-8167.2005.04730.x.
3
Recall alerts in implantable cardioverter-defibrillator recipients: implications for patients and physicians.
Pacing Clin Electrophysiol. 2011 Jan;34(1):96-103. doi: 10.1111/j.1540-8159.2010.02918.x. Epub 2010 Oct 7.
4
Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1499-1506. doi: 10.1016/j.jacep.2017.08.017. Epub 2017 Nov 6.
5
Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
Europace. 2013 Apr;15(4):531-40. doi: 10.1093/europace/eus337. Epub 2013 Feb 13.
6
The Number of Recalled Leads is Highly Predictive of Lead Failure: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
J Invasive Cardiol. 2016 Dec;28(12):E198-E202.
7
8
Mechanical and electrical dysfunction of Riata implantable cardioverter-defibrillator leads.
Europace. 2014 Dec;16(12):1787-94. doi: 10.1093/europace/euu079. Epub 2014 May 19.
9
Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
Europace. 2016 Aug;18(8):1187-93. doi: 10.1093/europace/euv352. Epub 2015 Nov 12.
10
Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
J Am Heart Assoc. 2017 May 10;6(5):e005031. doi: 10.1161/JAHA.116.005031.
本文引用的文献
1
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Circulation. 2018 Sep 25;138(13):e272-e391. doi: 10.1161/CIR.0000000000000549.
2
Long-Term Performance of the Riata/ST Implantable Cardioverter-Defibrillator Lead.
Am J Cardiol. 2016 Mar 1;117(5):807-12. doi: 10.1016/j.amjcard.2015.12.013. Epub 2015 Dec 13.
3
Prospective nationwide fluoroscopic and electrical longitudinal follow-up of recalled Riata defibrillator leads in Denmark.
Heart Rhythm. 2014 Dec;11(12):2141-7. doi: 10.1016/j.hrthm.2014.07.003. Epub 2014 Jul 4.
Zotero 插件